Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion type Assertion NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_head.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion description "[In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_provenance.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion evidence source_evidence_literature NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_provenance.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion SIO_000772 17786301 NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_provenance.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion wasDerivedFrom befree-20150227 NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_provenance.
- NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_assertion wasGeneratedBy ECO_0000203 NP920689.RAwKGGzT3BSvXiD1BPiQPGfKhz__COfibxSTMzIxIPLxs130_provenance.